<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="2719,48432">Angiotensin II</z:chebi> (<z:chebi fb="0" ids="48432">AngII</z:chebi>) is a key <z:chebi fb="7" ids="16670">peptide</z:chebi> in cardiovascular homeostasis and is a ligand for the <z:chebi fb="0" ids="2719,48432">Angiotensin II</z:chebi> type 1 and 2 seven transmembrane receptors (AT(1)R and AT(2)R) </plain></SENT>
<SENT sid="1" pm="."><plain>The AT(1) receptor is a seven-transmembrane (7TM) G protein-coupled receptor (GPCR) mediating the majority of the physiological functions of <z:chebi fb="0" ids="48432">AngII</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The AT(1)R mediates its effects through both G protein-dependent and independent signaling, which can be separated by functionally selective <z:chebi fb="4" ids="48705">agonists</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study we investigate the effect of <z:chebi fb="0" ids="48432">AngII</z:chebi> and the β-arrestin biased <z:chebi fb="4" ids="48705">agonist</z:chebi> [SII]<z:chebi fb="0" ids="48432">AngII</z:chebi> on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion injury in rat hearts </plain></SENT>
<SENT sid="4" pm="."><plain>Isolated hearts mounted in a Langendorff perfused rat heart preparations showed that preconditioning with [SII]<z:chebi fb="0" ids="48432">AngII</z:chebi> reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size induced by global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> from 46±8.4% to 22±3.4% </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, neither preconditioning with <z:chebi fb="0" ids="48432">AngII</z:chebi> nor postconditioning with <z:chebi fb="0" ids="48432">AngII</z:chebi> or [SII]<z:chebi fb="0" ids="48432">AngII</z:chebi> had a protective effect </plain></SENT>
<SENT sid="6" pm="."><plain>Together these results demonstrate a cardioprotective effect of simultaneous blockade of G protein signaling and activation of G protein independent signaling through AT(1) receptors </plain></SENT>
</text></document>